David E. Weinstein
Amministratore Delegato presso David Weinstein Consulting, Inc.
Provenienza dei contatti di primo grado di David E. Weinstein
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
National Institute of Neurological Disorders & Stroke
5
| Government | General Government | 5 |
Public Company | Pharmaceuticals: Major | 3 | |
Rivertown Therapeutics, Inc.
Rivertown Therapeutics, Inc. BiotechnologyHealth Technology Rivertown Therapeutics, Inc. develops novel and topically applied prescription products. The company was founded by Michael Altman and David Weinstein in 2015 and is headquartered in Dobbs Ferry, NY.
2
| Private Company | Biotechnology | 2 |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a David E. Weinstein tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Stanford University | College/University | Corporate Officer/Principal | |
BEZEQ THE ISRAEL TELECOMMUNICATION CORP. LTD | Major Telecommunications | Corporate Officer/Principal | |
George Washington University | College/University | Undergraduate Degree | |
Cranfield University | College/University | Doctorate Degree | |
Asset Management Co.
Asset Management Co. Investment ManagersFinance Asset Management Co. is a venture capital firm. The company was founded in 1965 and is headquartered in East Palo Alto, CA. | Investment Managers | Corporate Officer/Principal | |
The Hebrew University of Jerusalem | College/University | Masters Business Admin | |
United Way of Tucson & Southern Arizona, Inc.
United Way of Tucson & Southern Arizona, Inc. Miscellaneous Commercial ServicesCommercial Services United Way of Tucson & Southern Arizona, Inc. provides health and human services. The firm’s programs include cradle to career, days of caring and volunteer income tax assistance. The Company is headquartered in Tucson, AZ. | Miscellaneous Commercial Services | Director/Board Member | |
Translational Genomics Research Institute
Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Miscellaneous Commercial Services | Director/Board Member | |
NanoPass Technologies Ltd.
NanoPass Technologies Ltd. Pharmaceuticals: MajorHealth Technology NanoPass Technologies Ltd. develops and manufactures pharmaceuticals. It offers MicronJet needle which is a painless Intradermal Injection. The company was founded by Shuki Yeshurun in 2000 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Viola Partners
Viola Partners Investment ManagersFinance Viola Partners (Viola Partners) is a private equity subsidiary of Viola Group founded in 2000. The firm is headquartered in Herzliya, Hamerkaz. | Investment Managers | Private Equity Investor | |
NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Pharmaceuticals: Major | Director/Board Member | |
Peninsula Ltd.
Peninsula Ltd. Financial ConglomeratesFinance Peninsula Financial Ltd. operates as a factoring company that offers cash flow solutions for businesses. It services include domestic factoring, import/export factoring, supplier financing solutions, reverse factoring products, international trade finance, international commercial debt collection, brokering debt and equity financing, and financial consulting. The company was founded in 2004 and is headquartered in Tel Aviv, Israel. | Financial Conglomerates | Chairman | |
Genetic Alliance, Inc.
Genetic Alliance, Inc. Medical/Nursing ServicesHealth Services Genetic Alliance, Inc. provides health care services through genetics. Its customers include parent and family groups, community organizations, professional societies, corporations, and government agencies. The company was founded by Joan O. Weiss in 1986 and is headquartered in Washington, DC. | Medical/Nursing Services | Director/Board Member | |
Helix Ventures LLC
Helix Ventures LLC Investment ManagersFinance Helix Ventures LLC (Helix Ventures) is a venture capital firm founded in 2008 by Graham Crooke, Philip Sawyer and Evgeny Zaytsev. The firm is headquartered in Palo Alto, California. | Investment Managers | Founder | |
Archimedes Global Ltd.
Archimedes Global Ltd. Financial ConglomeratesFinance Archimedes Global Ltd. engages in investments in the health insurance businesses. Its services include consultancy, management, and business networking in the in the medical, insurance, and financial sectors. The company was founded by Yaron Inbar in May 2006 and is headquartered in Tel Aviv, Israel. | Financial Conglomerates | Director/Board Member | |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
CLEARSIDE BIOMEDICAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
RMI Partners OOO
RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100 percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit. RMI was founded in 2012 headquartered in Russian. The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Investment Managers | Corporate Officer/Principal | |
The Ara Parseghian Medical Research Foundation | Founder | ||
Archimedes Health Developments Ltd.
Archimedes Health Developments Ltd. Financial ConglomeratesFinance Archimedes Health Developments Ltd. provides investment services in the healthcare industry. The company is based in Limassol, Cyprus. and has subsidiaries in Israel. | Financial Conglomerates | Director/Board Member | |
Cellular Research, Inc.
Cellular Research, Inc. BiotechnologyHealth Technology Cellular Research, Inc. operates as a biotechnology research and development company. It offer Precise assays that provides quantitation of mRNA targets in single cells and small samples; precise predefined gene expression panels; and Pixel system, a detection platform for direct mRNA quantitation from single cells and rare samples. The company’s products are used in various applications that include gene expression validation, RNA-seq validation, pathway validation, and rare transcript detection. The company was founded by Stephen P. A. Fodor, Ari Chaney, Stephen R. Quake and Glenn Fu in 2011 and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member | |
University of Luton | College/University | Undergraduate Degree | |
Harvard Business School | College/University | Masters Business Admin | |
Stanford Graduate School of Business | College/University | Masters Business Admin | |
Genome Bridge | Chief Executive Officer | ||
ARVINAS, INC. | Biotechnology | Director/Board Member | |
Medico-Ecological Institute | College/University | Chief Tech/Sci/R&D Officer | |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Medical Specialties | Founder | |
Global Data Center Ltd.
Global Data Center Ltd. Data Processing ServicesTechnology Services Global Data Center Ltd. provides advanced data center services, ranging from server hosting to cloud computing. It specializes in server hosting, cloud computing, storage & communication infrastructure, tier iii energy infrastructure, control & monitoring of all systems, access to communication, drp services and backup services. The company was founded by Moshe Lasman and is headquartered in Herzeliya, Israel. | Data Processing Services | Director/Board Member | |
Global Genes
Global Genes Miscellaneous Commercial ServicesCommercial Services Global Genes is a non-profit organization that connects, empowers, and inspires the rare disease community to become more effective on their own behalf. The non-profit company is based in Aliso Viejo, CA and has subsidiaries in the United States. The company serve more than 400 million people around the globe and nearly one in 10 Americans affected by rare diseases. The organization helps spur innovation, meet essential needs, build capacity and knowledge, and drive progress within and across rare diseases. Global Genes was founded in 2008 and the CEO is Craig Martin. | Miscellaneous Commercial Services | Director/Board Member | |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Network For Excellence In Neuroscience Clinical Trials | Corporate Officer/Principal | ||
VENTYX BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Hc Bioscience, Inc.
Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology hC Bioscience, Inc. is a biotech company based in Cambridge, MA and has subsidiaries in the United States. A single trna therapy has the potential to treat many diseases, regardless of the gene or location of the mutation. hC Bioscience is dedicated to improving the lives of patients by developing first-in-class trna-based therapeutics that target protein dysfunction. The company's innovative approach to precision protein editing has the potential to treat genetically defined conditions that account for 10-15% of all human diseases. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). The company was founded in 2021 by Leslie J. Williams, who has been the CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
Israel Legacy Partners | Investment Managers | Founder | |
Bering Capital LLC
Bering Capital LLC Investment ManagersFinance Bering Capital LLC (Bering Capital) is a venture capital firm founded in 2020 by Evgeny Zaytsev. The firm is headquartered in San Francisco, California. | Investment Managers | Founder |
Statistiche
Distribuzione geografica
Stati Uniti | 36 |
Israele | 9 |
Regno Unito | 4 |
Russia | 3 |
Irlanda | 2 |
Settori
Health Technology | 23 |
Finance | 11 |
Consumer Services | 9 |
Commercial Services | 5 |
Communications | 2 |
Posizioni
Director/Board Member | 68 |
Corporate Officer/Principal | 17 |
Independent Dir/Board Member | 10 |
Founder | 9 |
Private Equity Investor | 7 |
Contatti più connessi
Insiders | |
---|---|
Augustine Lawlor | 43 |
Bradley Margus | 19 |
Evgeny Zaytsev | 14 |
Ellen Baron | 12 |
Eylon Penchas | 10 |
Allison Hulme | 9 |
Cindy Parseghian | 6 |
Deborah G. Hirtz | 1 |
Story C. Landis | 1 |
Michael Altman | 1 |
Steven Weinstock | 1 |
Lorna Role | 1 |
- Borsa valori
- Insiders
- David E. Weinstein
- Connessioni Società